Anti-GREM1 / Gremlin 1

In 1X PBS, pH 7.4, with 0.09% sodium azide. GREM1, also referred to as Gremlin 1, is a protein that plays a crucial role in a variety of biological processes, ranging from embryonic development to cancer progression. This multifunctional protein is a member of the BMP (Bone Morphogenetic Protein) antagonist family and is known for its ability to regulate cell growth, differentiation, and survival. One of the most intriguing aspects of GREM1 is its role in embryonic development. Studies have shown that this protein is essential for proper development of various tissues and organs, such as the lung, kidney, and limb. Additionally, GREM1 has been implicated in the formation of certain structures in the developing embryo, highlighting its importance in shaping the body's overall architecture. In addition to its role in embryonic development, GREM1 has also been linked to various diseases, particularly cancer. Research has shown that abnormal levels of Gremlin 1 are associated with tumor growth, invasion, and metastasis in several types of cancer, including colorectal, ovarian, and pancreatic cancer. This suggests that targeting GREM1 could potentially be a novel strategy for combating cancer progression. GREM1 has recently gained attention for its potential as a therapeutic target in certain diseases. Protein function: Cytokine that may play an important role during carcinogenesis and metanephric kidney organogenesis, as BMP a antagonist required for early limb outgrowth and patterning in maintaining the FGF4-SHH feedback loop (PubMed:12808456, PubMed:15201225). Down-regulates the BMP4 signaling in a dose-dependent manner (PubMed:15133038). Antagonist of BMP2, inhibits BMP2-mediated differentiation of osteoblasts (in vitro). Acts as inhibitor of monocyte chemotaxis. [The UniProt Consortium]